CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
MEBIAS Discovery is in the field of pathway-selective G-protein coupled receptor drug discovery. MEBIAS was founded to establish an alternative discovery model, offering a validated drug discovery platform. MEBIAS' business model foresees partnering ...Show all
Company (Alive / Active)
Phone: 267-536-4125
3025 Market Street
Suite 140
Philadelphia, 19104
Pennsylvania, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same | Jan 17, 2018 | Nov 17, 2020 | Patent |
| Substituted ureas and methods of making and using same | Aug 31, 2017 | Jun 16, 2020 | Patent |
| Substituted ureas and methods of making and using same | May 18, 2020 | Application |
